Brief: Acadia Pharmaceuticals Q1 EPS USD 0.11 Vs. IBES Estimate USD 0.11
07/05/2025 21:05
May 07 (Reuters) - Acadia Pharmaceuticals Q1 net income USD 18.987 million vs. IBES estimate USD 18.3 million. Q1 pretax profit USD 27.779 million vs. IBES estimate USD 21.6 million Q1 product sales USD 244.317 million vs. IBES estimate USD 239.3 million Q1 operating expenses USD 225.027 million
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP